Wednesday, July 15, 2026
VideoAdmin
NewsWhite
AstraZeneca's trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?
WORLD
Unverified

AstraZeneca's trial flop raises a bigger question: Is its pipeline premium becoming more vulnerable?

July 11, 2026·Source: CNBC·0 views

Share This Article

For years, AstraZeneca has commanded one of the richest valuations among large European pharma companies on the assumption that it consistently delivers results.

Share This Article

Originally reported by CNBC. Read the original article

Related Articles

Jordan Walker is your 2026 Home Run Derby champion...
WORLD

Jordan Walker is your 2026 Home Run Derby champion...

We have your one-stop shop for the most power-packed day of the baseball year as the 2026 Derby champion is crowned.

ESPN·20h ago
Haaland, Norway return home to heroes' welcome
WORLD

Haaland, Norway return home to heroes' welcome

Erling Haaland and his Norway teammates were welcomed home by a crowd of thousands following their historic World Cup achievements in North America.

ESPN·21h ago
Koundé: No 'lack of respect' in Yamal's France jib...
WORLD

Koundé: No 'lack of respect' in Yamal's France jib...

Jules Koundé said Monday that Spain winger Lamine Yamal's comments that France should fear the defending Euro champions ahead of their FIFA World Cup semifinal weren't a sign of disrespect.

ESPN·21h ago
McBride, Miles combine for 70 points in Lynx win
WORLD

McBride, Miles combine for 70 points in Lynx win

Minnesota rookie Olivia Miles scored a career-high 33, becoming the first WNBA player to reach 400 points, 100 rebounds and 100 assists in only 22 career games, and the Lynx defeated the Phoenix Mercury 104-100 Monday night for a third straight victory.

ESPN·21h ago